Literature DB >> 31386380

Identification of an Anti-MRSA Cyclic Lipodepsipeptide, WBP-29479A1, by Genome Mining of Lysobacter antibioticus.

Moli Sang1, Haoxin Wang1, Yuemao Shen2, Nathalia Rodrigues de Almeida3, Martin Conda-Sheridan3, Shanren Li4, Yaoyao Li2, Liangcheng Du4.   

Abstract

Lysobacter are ubiquitous in the environment but remain largely underexplored, although the bacteria are considered "peptide specialists". Here, we identified a new cyclic lipodepsipeptide, WBP-29479A1 (1), through genome mining of L. antibioticus ATCC 29479. 1 is biosynthesized by a large NRPS gene cluster, and its structure, including the six nonproteinogenic residues and 3-hydroxy fatty acid, was determined by extensive spectroscopic analyses and chemical derivatization. 1 exhibits potent anti-MRSA activity in a menaquinone-dependent manner.

Entities:  

Year:  2019        PMID: 31386380     DOI: 10.1021/acs.orglett.9b02333

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  2 in total

Review 1.  Strategies to access biosynthetic novelty in bacterial genomes for drug discovery.

Authors:  Franziska Hemmerling; Jörn Piel
Journal:  Nat Rev Drug Discov       Date:  2022-03-16       Impact factor: 84.694

2.  Identification of structurally diverse menaquinone-binding antibiotics with in vivo activity against multidrug-resistant pathogens.

Authors:  Lei Li; Bimal Koirala; Yozen Hernandez; Logan W MacIntyre; Melinda A Ternei; Riccardo Russo; Sean F Brady
Journal:  Nat Microbiol       Date:  2021-12-23       Impact factor: 30.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.